YC S17Inactive
Spect
Value-based retinal screening in primary care to prevent blindness.
About
Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.
Founders
- Rishab Gargeya
- Ted Leng
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Spect.
See family office activityIndustry & Focus
HealthcareConsumer Health and WellnessDigital HealthAI